BOQI International Medical Forms New Subsidiary, BOYI Technology, To Generate Revenue In Healthcare Technology Industry
February 11 2020 - 8:30AM
BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the
“Company”) today announced the formation and business plan of its
new wholly-owned subsidiary, BOYI Technology, a healthcare
technology company focused on developing and marketing Telehealth
software, eProcurement platform and supply-chain-management
software (SCMS) for the healthcare industry.
The formation of BOYI Technology is in line with BOQI
International Medical’s member-centric O2O business model, while
also meeting the increasing market demand for Telehealth software
and healthcare SCMS. BOYI Technology will be based in Dalian,
China, with initial product availability expected in the second
quarter of the calendar year 2020. BOYI Technology plans to develop
and market four specific software in 2020: eProcurement platform,
SCMS, Telemedicine software and Chronic Care Management(CCM)
system.
The eProcurement platform is for clinics and pharmacies to help
them digitalize procurement and increase efficiencies. The platform
will be connected to the ERP system of upstream pharmaceutical
companies, reducing users’ operating costs and automating order
processing.
The SCMS is for pharmaceutical companies, hospitals clinics and
pharmacies to keep tighter control of internal inventories,
internal production, distribution, sales, and the inventories of
their vendors. The SCMS is expected to classify medicines by
therapeutic use, find medicines with overlapping effects and low
gross profit margins, and optimize inventory management.
The Telemedicine software is for medical specialists and
individual users. Users can enjoy one-to-one online consultation
services provided by nearby medical specialists. When a referral is
needed, the patient can make an online appointment and share all
medical records, prescriptions, and test results with the
higher-level healthcare provider.
The CCM system is mainly for elderly customers with chronic
disease. The system will record health data (blood glucose, blood
pressure, blood lipids, oxygen levels, etc.) uploaded by wearable
equipment, which will provide clinical decision support for
physicians.
"The online business has always been a critical component of our
growth strategy," said Mr. Tiewei Song, Chief Executive Officer and
President of BOQI International Medical Inc. "During the outbreak
of the coronavirus, we are accelerating the development of
Telehealth software and the supply chain management systems to meet
the immediate needs of our customers. We believe that our online
business will play an important role in generating revenue this
year as travel restrictions may be widening."
About BOQI International Medical Inc.
BOQI International Medical Inc. (formerly known as NF Energy
Saving Corporation) (NASDAQ: BIMI) was founded in 2006. In February
2019, the Board of Directors of the company was reorganized
following efforts led by Mr. Yongquan Bi, the company’s new
Chairman, with a renewed focus on the health industry. The company
is now transforming from a provider of integrated energy
conservation solutions utilizing energy-saving equipment, technical
services and energy management re-engineering project operations to
a medical and health service provider. BOQI International Medical
Inc. offers a broad range of consumer-directed health products and
related services, including medical, pharmacy and behavioral health
plans, chronic disease management services, and health information
technology products and services. BOQI International Medical Inc.
is community-based and locally focused, engaging consumers with
more affordable, accessible, simple and seamless care they need
when and where they need it.
Safe Harbor Statement
The statements contained herein that are not historical facts
are considered “forward-looking statements.” Such forward-looking
statements may be identified by, among other things, the use of
forward-looking terminology such as “believes,” “expects,” “may,”
“will,” “should,” or “anticipates” or the negative thereof or other
variations thereon or comparable terminology, or by discussions of
strategy that involve risks and uncertainties. In particular,
statements regarding the efficacy of investment in research and
development are examples of such forward-looking statements. The
forward-looking statements include risks and uncertainties,
including, but not limited to, the effect of political, economic,
and market conditions and geopolitical events; legislative and
regulatory changes that affect our business; the availability of
funds and working capital; the actions and initiatives of current
and potential competitors; investor sentiment; and our reputation.
We do not undertake any responsibility to publicly release any
revisions to these forward-looking statements to take into account
events or circumstances that occur after the date of this report.
Additionally, we do not undertake any responsibility to update you
on the occurrence of any unanticipated events, which may cause
actual results to differ from those expressed or implied by any
forward-looking statements. The factors discussed herein are
expressed from time to time in our filings with the Securities and
Exchange Commission available at http://www.sec.gov.
IR Contact:Dragon Gate Investment Partners
LLCTel: +1(646)-801-2803Email: BIMI@dgipl.com
BIMI International Medical (NASDAQ:BIMI)
Historical Stock Chart
From Mar 2024 to Apr 2024
BIMI International Medical (NASDAQ:BIMI)
Historical Stock Chart
From Apr 2023 to Apr 2024